TrialClinical cancer research : an official journal of the American Association for Cancer Research2020

A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.

Amit M Oza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.